Thomas E Wales (Thomas Wales)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 15

Top Topics

Molecular Dynamics Simulations

Cell Cycle Arrest

Chronic Lymphocytic Leukemia

Endoplasmic Reticulum

Top Venues

Nature chemical biology

bioRxiv : the preprint server for biology

Nature structural & molecular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew W McHenry, Peiwen Shi, Christina M Camara, Daniel T Cohen, T Justin Rettenmaier, Utsarga Adhikary, Micah A Gygi, Ka Yang, Steven P Gygi, Thomas E Wales, John R Engen, James A Wells, Loren D Walensky
Covalent inhibition of pro-apoptotic BAX. Nature chemical biology (2024)
David Yin-Wei Lin, Lauren E Kueffer, Puneet Juneja, Thomas E Wales, John R Engen, Amy H Andreotti
Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states. eLife 12 (2024)
Matthew W McHenry, Peiwen Shi, Christina M Camara, Daniel T Cohen, T Justin Rettenmaier, Utsarga Adhikary, Micah A Gygi, Ka Yang, Steven P Gygi, Thomas E Wales, John R Engen, James A Wells, Loren D Walensky
Covalent inhibition of pro-apoptotic BAX. Nature chemical biology 20 (8) (2024)
David Yin-Wei Lin, Lauren E Kueffer, Puneet Juneja, Thomas E Wales, John R Engen, Amy H Andreotti
Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states. eLife 12 (2024)
Thomas E Wales, Aleksandra Pajak, Alžběta Roeselová, Santosh Shivakumaraswamy, Steven Howell, Svend Kjær, F Ulrich Hartl, John R Engen, David Balchin
Resolving chaperone-assisted protein folding on the ribosome at the peptide level. Nature structural & molecular biology (2024)
Matthew W McHenry, Peiwen Shi, Christina M Camara, Daniel T Cohen, T Justin Rettenmaier, Utsarga Adhikary, Micah A Gygi, Ka Yang, Steven P Gygi, Thomas E Wales, John R Engen, James A Wells, Loren D Walensky
Covalent inhibition of pro-apoptotic BAX. Nature chemical biology (2024)
Matthew W McHenry, Peiwen Shi, Christina M Camara, Daniel T Cohen, T Justin Rettenmaier, Utsarga Adhikary, Micah A Gygi, Ka Yang, Steven P Gygi, Thomas E Wales, John R Engen, James A Wells, Loren D Walensky
Covalent inhibition of pro-apoptotic BAX. Nature chemical biology (2024)
Matthew W McHenry, Peiwen Shi, Christina M Camara, Daniel T Cohen, T Justin Rettenmaier, Utsarga Adhikary, Micah A Gygi, Ka Yang, Steven P Gygi, Thomas E Wales, John R Engen, James A Wells, Loren D Walensky
Covalent inhibition of pro-apoptotic BAX. Nature chemical biology (2024)
David Yin-Wei Lin, Lauren E Kueffer, Puneet Juneja, Thomas E Wales, John R Engen, Amy H Andreotti
Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states. eLife 12 (2024)
David Yin-Wei Lin, Lauren E Kueffer, Puneet Juneja, Thomas E Wales, John R Engen, Amy H Andreotti
Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states. eLife 12 (2024)
Matthew W McHenry, Peiwen Shi, Christina M Camara, Daniel T Cohen, T Justin Rettenmaier, Utsarga Adhikary, Micah A Gygi, Ka Yang, Steven P Gygi, Thomas E Wales, John R Engen, James A Wells, Loren D Walensky
Covalent inhibition of pro-apoptotic BAX. Nature chemical biology (2024)
David Yin-Wei Lin, Lauren E Kueffer, Puneet Juneja, Thomas E Wales, John R Engen, Amy H Andreotti
Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states. eLife 12 (2024)
Matthew W McHenry, Peiwen Shi, Christina M Camara, Daniel T Cohen, T Justin Rettenmaier, Utsarga Adhikary, Micah A Gygi, Ka Yang, Steven P Gygi, Thomas E Wales, John R Engen, James A Wells, Loren D Walensky
Covalent inhibition of pro-apoptotic BAX. Nature chemical biology 20 (8) (2024)
David Yin-Wei Lin, Lauren E Kueffer, Puneet Juneja, Thomas E Wales, John R Engen, Amy H Andreotti
Conformational heterogeneity of the BTK PHTH domain drives multiple regulatory states. bioRxiv : the preprint server for biology (2023)
Raji E Joseph, Thomas E Wales, Sandrine Jayne, Robert Graham Britton, D Bruce Fulton, John R Engen, Martin J S Dyer, Amy H Andreotti
Impact of the clinically approved BTK inhibitors on the conformation of full-length BTK and analysis of the development of BTK resistance mutations in chronic lymphocytic leukemia. bioRxiv : the preprint server for biology (2023)